Pharmacists in Ashtabula, Ohio


29 Pharmacists found in Ashtabula
male pharmacist

Michael J Steen, PHARMD, RPH


Pharmacist
1819 E Prospect Rd, Ashtabula, OH 44004
440-998-2216    

male pharmacist

Mr. Michael E Fusek Iii, RPH


Pharmacist
3819 Edgewater Dr, Ashtabula, OH 44004
330-518-7449    

female pharmacist

Michele Lee Hockran



2801 C Ct, Ashtabula, OH 44004
440-998-4210     440-998-2247



female pharmacist

Mrs. Nicole Ann Pankuch


Pharmacist
2148 Lake Ave, Ashtabula, OH 44004
440-993-0906    

male pharmacist

Dr. Paul Anthony Clemens, RPH, PHARMD


Pharmacist
3551 N Ridge East, Ashtabula, OH 44004
440-998-4004     440-998-0589

male pharmacist

Peter Schumann


Pharmacist
318 W Prospect Rd, Ashtabula, OH 44004
440-992-3522    

female pharmacist

Mrs. Rachel Leigh Harpst, PHARM.D.


Pharmacist
1115 W Prospect Rd, Ashtabula, OH 44004
440-998-3777    

female pharmacist

Sarah Mackenzie Fowler


Pharmacist
2323 Lake Ave, Ashtabula, OH 44004
440-992-3000    

male pharmacist

Mr. Scott S Coursen, RPH


Pharmacist
3315 N Ridge Rd E Ste 100, Ashtabula, OH 44004
440-992-7477     440-992-1513

male pharmacist

Sean Mccracken, PHARMD


Pharmacist
1115 W Prospect Rd, Ashtabula, OH 44004
440-998-3777    

female pharmacist

Shannon Lee Pratschler, RPH


Pharmacist
1115 W Prospect Rd, Ashtabula, OH 44004
440-998-3777     440-998-1471

male pharmacist

Tim Erickson


Pharmacist
3551 N Ridge Rd E, Ashtabula, OH 44004
440-998-4004    

male pharmacist

Mr. Travis Isenberg, PHARMD


Pharmacist
1819 E Prospect Rd, Ashtabula, OH 44004
440-998-2216     440-992-3322


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.